MTN-020 Common QCs and Form Completion Questions

Slides:



Advertisements
Similar presentations
1 MTN-003 Training Follow-up Visit Scheduling and Visit Coding SSP Sections and
Advertisements

Overview of Follow-up Visit Types and Visit Scheduling Training Binder Tab: Follow-up Visits.
CROMS NIDCR Clinical Monitoring
ASPIRE Off-Site Visits. Rationale Why make an allowance for off-site visits in the protocol? Adherence & Retention Off-site visits Improving Clinic Flow.
HIV Counseling &Testing. Page 346 HIV and Risk Reduction (RR) Counseling Required at all scheduled visits Includes HIV Pre- and Post-test counseling.
ASPIRE TRAINING RANDOMIZATION & INITIAL DISPENSING Cindy Jacobson, PharmD (MTN) Jen Berthiaume/Missy Cianciola (SCHARP)
Reportable AEs – Report on AE Log CRF
G ENITAL B LEEDING ASPIRE SSP Section Updates 31 January 2014.
Study Product Adherence Counseling At Follow-up Visits
1 Year 2 Highlights MARC MARC-35 Sites: Year 2.
1 MTN-003 Training Specimen Labeling and Preparation for Entry into LDMS.
Contraception/Pregnancies MTN 020. Why do we care? Participants must come off product during pregnancy and breastfeeding – Studies of dapivirine in pregnant.
1 DataFax Overview and CRF Completion MTN 003 Training.
Baseline Medical and Menstrual History The ins, outs, ups, and downs of collecting a relevant and complete baseline medical/menstrual history MTN 020 Training.
Genital Bleeding MTN 020 Training. Background  Genital Bleeding is common Includes menses Includes intermenstrual bleeding (IMB)  Determining whether.
Developed by Klinikos; Roy Fraser (2012) Investigator Study File
MTN-027 Screening Visit Procedures. SSP Manual References Protocol Section 7.2 and Table 10 (Screening) Section 4: Study Procedures Section 5: Informed.
Information for students Welcome to the S 3 P system. Login to the system by entering your User ID and password. The User ID is the same as your normal.
1 MTN 003 Data Management Considerations SSP Sections 14, 15 & 17.
ASPIRE TRAINING Study Product Considerations & Accountability for Non-Pharmacy Staff.
MTN-028 Enrollment Visit Procedures Phase 1 Pharmacokinetic Trial of Two Intravaginal Rings (IVRs) Containing Different Dose Strengths of Vicriviroc (MK-4176)
Home screen of your online tracker system Updates or notes for your attention are placed at the top in red. This will also inform you of the document turnaround.
ACRIN 6698 Diffusion-weighted MRI Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: An I-SPY 2 Trial Substudy Presented by:
Online Data Management System: Navigating the ACRIN Website Page 1.
Overview of Enrollment Procedures. Training Materials for this session  All materials for this session can be found under the Enrollment tab of your.
Introduction to iDataFax
MTN-027 Laboratory Related CRFs. Pharmacokinetics Specimens (PKS-1) - Enrollment, Day 28 Pharmacokinetics Specimens (PKD-1) - Days 1, 2, 3, 7, 14, 21,
SMART Study Closeout Washington ICC Meeting 03 June 2007.
Follow-up Visit Procedures MTN-028 Study Specific Training.
MTN-027 Clinical Management CRFs. CRFs for Clinical Management Physical Exam Pelvic Exam Diagrams Pelvic Exam Pelvic Exam Ring Assessment Clinical Product.
Investigator’s Meeting
**INSERT YOUR TITLE HERE**
Protocol Deviations. MTN protocol deviation policy  MTN has recently revised their policy on PDs- this policy will be made available on the MTN website.
MTN-028 Laboratory Related CRFs. Pharmacokinetics Specimens (PKS-1) - Enrollment, Day 28 Pharmacokinetics Specimens (PKD-1) - Days 1, 2, 3, 7, 14, 21,
Social Harms Reporting in ASPIRE Training Binder p.275.
Follow-up Case Report Forms SCHARP. Follow-up Visit CRFs Monthly Visits Date of Visit Follow-up Visit Summary Ring Adherence (Y/N) prompt Laboratory Results.
Participant Tracking Database (PTD) Overview Access database is an optional tool for tracking participant visit scheduling and visits throughout HOPE.
MTN-025/HOPE Decliner Population Procedures. Who are the Decliner Population? Former ASPIRE participants who decline or express no interest in joining.
Overview of Key Clinical Considerations MTN 025 Training.
MTN-025 (HOPE) Data Management Training: Prescreening Statistical Center for HIV/AIDS Research & Prevention (SCHARP) Fred Hutchinson Cancer Research Center.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
IMPAACT 2010 Screening Visits
Søren Marker Jensen, MD, coordinating investigator
Planning for HOPE PUEVs and Study Exit Visits
Verification of Study Online
Overview of Visit Scheduling and Types of Follow-up Visits SCHARP
IMPAACT 2010 Screening Visits
Protocol Deviations.
Management of Pregnancies
30 April 2015 Updated 29 December 2015
HOW TO ENTER BASELINE DATA
MTN-025 Data Communiqué #1 CRF Updates.
USAJOBS – Application Manager
HOPE STUDY PRODUCT TRAINING PHASE 2
Protocol References Section Title 6.2 Entry Visit 5.1
IMPAACT 2010 Screening Visits
MTN-037 Training Julie Ngo SCHARP April 12, 2018.
MTN-037 Screening and Enrollment
MTN-037 Study Product Considerations
Key points.
Social Harms Reporting in MTN-017
Overview of Enrollment Procedures
PRE CRF at Enrollment Visit
HOW TO ENTER BASELINE DATA
Administering Behavioral CRFs
You must log in using both you address and your Full name before proceeding
HOPE STUDY PRODUCT TRAINING
ASPIRE Common QCs - PUEV and SEV
Serious Adverse Event Reconciliation
Presentation transcript:

MTN-020 Common QCs and Form Completion Questions November 23, 2018

What are most common QCs and data queries in ASPIRE so far? Let’s see some examples...

Eligibility Criteria (ECI-1) CRF Form Completion Date If a participants rescreens for ASPIRE, update the original ECI-1 from the initial screening attempt for that participant with her eligibility information, initial and date all items updated and fax to SCHARP Remember to also update the Form Completion Date to the date of the reassessment

Screening Menstrual History (SMH-1) CRF Item 4: Usual Number of bleeding days (record range) If the participant’s usual maximum number of bleeding days is greater than 99 days, record ‘99’ in Item 4 and provide details in Item 8 as needed

Screening Menstrual History (SMH-1) CRF Item 6: If the participant’s menses is ongoing at her Screening Visit, mark ‘ongoing’ in Item 6 and do not revise this CRF at a later date when known. This date will be collected on the Baseline Family Planning CRF at Enrollment.

Screening/Quarterly Laboratory Results (SLR-1, QLR-1) CRF Item 2c. Creatinine Only one value should be completed for creatinine Space is provided to record the value reported on the site’s lab results form This QC can be resolved by lining through one of the options, initial/date and refax to SCHARP

Visit Summary (VS-1) CRF Items 6 & 7 If a Visit Summary is completed at an interim visit, per the skip instruction highlighted, items 6 & 7 should be skipped as any new AE-1 or PH- log pages will be documented in Item 5.

Documentation of Missed Visits on MV-1 A missed scheduled visit should be documented on the Missed Visit (MV-1) CRF. While this is a protocol deviation, a PDL-1 does not need to be completed. Item 3 on MV-1 (corrective action plan) is sufficient documentation to address the deviation.

Ring Adherence (RA-1) CRF Item 1: If a participant missed the last scheduled monthly visit previous, and was dispensed a ring at her last visit, item 1 should be marked ‘yes’. The remaining items pertain to the previous month only.

Ring Collection/Insertion (RCI-1) CRF Pay particular attention to the skip patterns on this form! Ex: If Item 2 ‘number of used rings collected’ is ‘none’, ‘2’, or ‘3’, a reason is required in Item 2a. If ‘1’, go to Item 3. Ex: If a new ring is not dispensed and item 4a is completed, skip items 5 and 6 and complete Item 7, ‘Appearance of the ring’

Specimen Storage (SS-1) CRF Item 2a If Item 2 (endocervical swab for biomarkers) is marked as ‘stored’, item 2a, “Was blood visible on the swab?” must be completed.

Questions? Please contact Jen Berthiaume and Karen Patterson with any questions you have about this slide presentation. Email us at: jberthia@scharp.org karenp@scharp.org